Seminars in Ultrasound, CT and MRI
Volume 28, Issue 6 , Pages 451-461 , December 2007

3-Tesla MRI and Temporal Lobe Epilepsy

  • Juan Alvarez-Linera Prado, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Juan Alvarez-Linera Prado, La Masó 38, Madrid 28034, Spain.

References 

  1. Taillibert S, Oppenheim C, Baulac M, Dormont D, Marsault C, Cabanis EA, et al. Yield of fluid-attenuated inversion recovery in drug-resistant focal epilepsy with noninformative conventional magnetic resonance imaging. Eur Neurol. 1999;41(2):64–72
  2. Duncan JS. Neuroimaging for epilepsy: quality and not just quantity is important. J Neurol Neurosurg Psychiatry. 2002;73(6):612–613
  3. Grant PE, Barkovich AJ, Wald LL, Dillon WP, Laxer KD, Vigneron DB. High-resolution surface-coil MR of cortical lesions in medically refractory epilepsy: a prospective study. AJNR Am J Neuroradiol. 1997;18(2):291–301
  4. Knake S, Triantafyllou C, Wald LL, Wiggins G, Kirk GP, Larsson PG, et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology. 2005;65(7):1026–1031
  5. Griffiths PD, Coley SC, Connolly DJ, Hodgson T, Romanowski CA, Widjaja E, et al. MR imaging of patients with localisation-related seizures: initial experience at 3.0T and relevance to the NICE guidelines. Clin Radiol. 2005;60(10):1090–1099
  6. Bronen RA, Fulbright RK, Spencer SS, Spencer DD, Kim JH, Lange RC. Economic impact of replacing CT with MR imaging for refractory epilepsy. Magn Reson Imaging. 1997;15(7):857–862
  7. Von Oertzen J, Urbach H, Jungbluth S, Kurthen M, Reuber M, Fernandez G, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002;73(6):643–647
  8. Briellmann RS, Pell GS, Wellard RM, Mitchell LA, Abbott DF, Jackson GD. MR imaging of epilepsy: state of the art at 1.5 T and potential of 3 T. Epileptic Disord. 2003;5(1):3–20
  9. Regula S, Briellmann GSP, Wellard RM, Mitchell LA, Abbott DF, Jackson GD. MR imaging of epilepsy: state of the art at 1.5 T and potential of 3 T. Epileptic Disord. 2003;5(1):3–20
  10. Frayne R, Goodyear BG, Dickhoff P, Lauzon ML, Sevick RJ. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol. 2003;38(7):385–402
  11. Roschmann P. Radiofrequency penetration and absorption in the human body: limitations to high-field whole-body nuclear magnetic resonance imaging. Med Phys. 1987;14(6):922–931
  12. Ibrahim TS, Lee R, Baertlein BA, Robitaille PM. B1 field homogeneity and SAR calculations for the birdcage coil. Phys Med Biol. 2001;46(2):609–619
  13. Inglese M, Spindler M, Babb JS, Sunenshine P, Law M, Gonen O. Field, coil, and echo-time influence on sensitivity and reproducibility of brain proton MR spectroscopy. AJNR Am J Neuroradiol. 2006;27(3):684–688
  14. Okada T, Yamada H, Ito H, Yonekura Y, Sadato N. Magnetic field strength increase yields significantly greater contrast-to-noise ratio increase: measured using BOLD contrast in the primary visual area. Acad Radiol. 2005;12(2):142–147
  15. Vlaardingerbroek MT. Magnetic Resonance Imaging: Theory and Practice. New York, NY: Springer-Verlag; 1999;DBJ
  16. Wieshmann UC, Free SL, Stevens JM, Shorvon SD. Image contrast and hippocampal volumetric measurements. Magn Reson Imaging. 1998;16(1):13–17
  17. Wattjes MP, Lutterbey GG, Harzheim M, Gieseke J, Traber F, Klotz L, et al. Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T. Eur Radiol. 2006;16(9):2067–2073
  18. Wattjes MP, Lutterbey GG, Gieseke J, Traber F, Klotz L, Schmidt S, et al. Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. AJNR Am J Neuroradiol. 2007;28(1):54–59
  19. Wattjes MP, Harzheim M, Kuhl CK, Gieseke J, Schmidt S, Klotz L, et al. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR imaging criteria for multiple sclerosis?. AJNR Am J Neuroradiol. 2006;27(8):1794–1798
  20. Di Costanzo A, Trojsi F, Tosetti M, Schirmer T, Lechner SM, Popolizio T, et al. Proton MR spectroscopy of the brain at 3 T: an update. Eur Radiol. 2007;
  21. Wu RH, Bruening R, Noachtar S, Arnold S, Berchtenbreiter C, Bartenstein P, et al. MR measurement of regional relative cerebral blood volume in epilepsy. J Magn Reson Imaging. 1999;9(3):435–440
  22. Liu HL, Kochunov P, Hou J, Pu Y, Mahankali S, Feng CM, et al. Perfusion-weighted imaging of interictal hypoperfusion in temporal lobe epilepsy using FAIR-HASTE: comparison with H(2)(15)O PET measurements. Magn Reson Med. 2001;45(3):431–435
  23. Cendes F. October 11 Highlights and Commentary: Higher resolution MRI and image modeling for predicting surgical outcome in partial epilepsy. Neurology. 2005;65(7):975
  24. Mueller SG, Laxer KD, Schuff N, Weiner MW. Voxel-based T2 relaxation rate measurements in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia. 2007;48(2):220–228
  25. Hammen T, Stefan H, Pauli E, Schafer I, Huk W, Tomandl B. 1H-MR spectroscopy: a promising method in distinguishing subgroups in temporal lobe epilepsy?. J Neurol Sci. 2003;215(1-2):21–25
  26. Sawaishi Y, Sasaki M, Yano T, Hirayama A, Akabane J, Takada G. A hippocampal lesion detected by high-field 3 tesla magnetic resonance imaging in a patient with temporal lobe epilepsy. Tohoku J Exp Med. 2005;205(3):287–291
  27. McBride MC, Bronstein KS, Bennett B, Erba G, Pilcher W, Berg MJ. Failure of standard magnetic resonance imaging in patients with refractory temporal lobe epilepsy. Arch Neurol. 1998;55(3):346–348
  28. Bocti C, Robitaille Y, Diadori P, Lortie A, Mercier C, Bouthillier A, et al. The pathological basis of temporal lobe epilepsy in childhood. Neurology. 2003;60(2):191–195
  29. Suhy J, Laxer KD, Capizzano AA, Vermathen P, Matson GB, Barbaro NM, et al. 1H MRSI predicts surgical outcome in MRI-negative temporal lobe epilepsy. Neurology. 2002;58(5):821–823
  30. Woermann FG, McLean MA, Bartlett PA, Parker GJ, Barker GJ, Duncan JS. Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol. 1999;45(3):369–376
  31. Mueller SG, Laxer KD, Suhy J, Lopez RC, Flenniken DL, Weiner MW. Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using hippocampal short-TE MRSI. Epilepsia. 2003;44(7):977–980
  32. Vermathen P, Laxer KD, Schuff N, Matson GB, Weiner MW. Evidence of neuronal injury outside the medial temporal lobe in temporal lobe epilepsy: N-Acetylaspartate concentration reductions detected with multisection proton MR spectroscopic imaging—initial experience. Radiology. 2003;226(1):195–202
  33. Shih JJ, Weisend MP, Lewine J, Sanders J, Dermon J, Lee R. Areas of interictal spiking are associated with metabolic dysfunction in MRI-negative temporal lobe epilepsy. Epilepsia. 2004;453:223–229
  34. Cohen-Gadol AA, Wilhelmi BG, Collignon F, White JB, Britton JW, Cambier DM, et al. Long-term outcome of epilepsy surgery among 399 patients with nonlesional seizure foci including mesial temporal lobe sclerosis. J Neurosurg. 2006;104(4):513–524
  35. Duzel E, Kaufmann J, Guderian S, Szentkuti A, Schott B, Bodammer N, et al. Measures of hippocampal volumes, diffusion and 1H MRS metabolic abnormalities in temporal lobe epilepsy provide partially complementary information. Eur J Neurol. 2004;11(3):195–205
  36. Goncalves Pereira PM, Oliveira E, Rosado P. Apparent diffusion coefficient mapping of the hippocampus and the amygdala in pharmaco-resistant temporal lobe epilepsy. AJNR Am J Neuroradiol. 2006;27(3):671–683
  37. Londono A, Castillo M, Lee YZ, Smith JK. Apparent diffusion coefficient measurements in the hippocampi in patients with temporal lobe seizures. AJNR Am J Neuroradiol. 2003;24(8):1582–1586
  38. Wehner T, Lapresto E, Tkach J, Liu P, Bingaman W, Prayson RA, et al. The value of interictal diffusion-weighted imaging in lateralizing temporal lobe epilepsy. Neurology. 2007;68(2):122–127
  39. Rugg-Gunn FJ, Eriksson SH, Symms MR, Barker GJ, Duncan JS. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain. 2001;124(3):627–636
  40. Medina LS, Bernal B, Ruiz J. Role of functional MR in determining language dominance in epilepsy and nonepilepsy populations: a Bayesian analysis. Radiology. 2007;242:94–100
  41. Benke T, Koylu B, Visani P, Karner E, Brenneis C, Bartha L, et al. Language lateralization in temporal lobe epilepsy: a comparison between fMRI and the Wada Test. Epilepsia. 2006;47(8):1308–1319
  42. Sabbah P, Chassoux F, Leveque C, Landre E, Baudoin-Chial S, Devaux B, et al. Functional MR imaging in assessment of language dominance in epileptic patients. Neuroimage. 2003;18(2):460–467
  43. Rabin ML, Narayan VM, Kimberg DY, Casasanto DJ, Glosser G, Tracy JI, et al. Functional MRI predicts post-surgical memory following temporal lobectomy. Brain. 2004;127(pt 10):2286–2298
  44. Richardson MP, Strange BA, Thompson PJ, Baxendale SA, Duncan JS, Dolan RJ. Pre-operative verbal memory fMRI predicts post-operative memory decline after left temporal lobe resection. Brain. 2004;127(pt 11):2419–2426

PII: S0887-2171(07)00079-0

doi: 10.1053/j.sult.2007.09.007

Seminars in Ultrasound, CT and MRI
Volume 28, Issue 6 , Pages 451-461 , December 2007

Article Tools

* Image Usage & Resolution